Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Prothrombin-complex-concentrate

Pulmonary-embolism : case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Jimenez CS, et al. Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy. European Journal of Hospital Pharmacy 28: E66-E71, No. 1, Nov 2021. Available from: URL: http://doi.org/10.1136/ejhpharm-2019-002114 Jimenez CS, et al. Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy. European Journal of Hospital Pharmacy 28: E66-E71, No. 1, Nov 2021. Available from: URL: http://​doi.​org/​10.​1136/​ejhpharm-2019-002114
Metadaten
Titel
Prothrombin-complex-concentrate
Pulmonary-embolism : case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41615-6

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Belantamab

Case report

Posaconazole

Case report

Olanzapine

Case report

Antineoplastics